Rectal Cancer Stage IV Clinical Trials

8 recruitingLast updated: June 18, 2026

There are 8 actively recruiting rectal cancer stage iv clinical trials across 6 countries. Studies span Early Phase 1, Phase 2, Not Applicable, Phase 1, Phase 3. Top locations include Milan, Italy, Mie, Japan, Barcelona, Spain. Updated daily from ClinicalTrials.gov.


Rectal Cancer Stage IV Trials at a Glance

8 actively recruiting trials for rectal cancer stage iv are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Early Phase 1 with 2 trials, with the heaviest enrollment activity in Milan, Mie, and Barcelona. Lead sponsors running rectal cancer stage iv studies include City of Hope Medical Center, Fred Hutchinson Cancer Center, and Biogenea Pharmaceuticals Ltd..

Browse rectal cancer stage iv trials by phase

Treatments under study

About Rectal Cancer Stage IV Clinical Trials

Looking for clinical trials for Rectal Cancer Stage IV? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Rectal Cancer Stage IV trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Rectal Cancer Stage IV clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting

Early Detection of Advanced Adenomas and Colorectal Cancer

Colorectal, CancerColorectal NeoplasmsColorectal Adenocarcinoma+15 more
City of Hope Medical Center2,000 enrolled6 locationsNCT06342440
Recruiting
Phase 2

Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab in the Treatment of Metastatic BRAF-mutated Colorectal Cancer Refractory

Colorectal, CancerColorectal Cancer Stage IVStage IV Colorectal Cancer Positive for BRAF V600E Mutation
Northwestern University43 enrolled8 locationsNCT05576896
Recruiting
Phase 1Phase 2

Cadonilimab for PD-1/PD-L1 Blockade-refractory, MSI-H/dMMR, Advanced Colorectal Cancer

Colorectal Cancer Stage IVMismatch Repair-deficient (dMMR)Microsatellite Instability-high (MSI-H)
Sun Yat-sen University28 enrolled1 locationNCT05426005
Recruiting
Not Applicable

Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial

Breast Cancer Stage IBreast Cancer Stage IIBreast Cancer Stage III+4 more
Fred Hutchinson Cancer Center100 enrolled1 locationNCT06802172
Recruiting

Early Onset Colorectal Cancer Detection

Colorectal, CancerColorectal NeoplasmsColorectal Adenocarcinoma+5 more
City of Hope Medical Center400 enrolled13 locationsNCT06342401
Recruiting
Early Phase 1

COLONYVAQ™, a Quantum-Classical Guided Personalized Neoantigen Vaccine for MSS Stage III Colorectal Cancer

Colorectal Cancer MetastaticColorectal Cancer Stage IIIColorectal Cancer Stage IV
Biogenea Pharmaceuticals Ltd.12 enrolled1 locationNCT07328087
Recruiting
Early Phase 1

A Dose-Expansion Trial of Intravenous HNF4α srRNA for Unresectable or Metastatic Colorectal Cancer

Colorectal Cancer MetastaticColorectal Cancer RecurrentColorectal Cancer Stage IV
Shanghai Changzheng Hospital20 enrolled1 locationNCT07050394
Recruiting
Phase 3

Intermittent or Continuous Panitumumab Plus FOLFIRI for Left Sided RAS/B-RAF Wild-type Metastatic Colorectal Cancer

Colorectal Cancer Stage IV
National Cancer Institute, Naples500 enrolled1 locationNCT06509126